LEADERSHIP & GOVERNANCE

Experience Across Markets, Industries, and Two Economies.

JP3E’s leadership and Board support disciplined execution across public markets, strategic assets, life sciences, institutional finance, and U.S.–Korea business development.

BOARD ROSTER / 2026

Portrait spaces are reserved for the final executive photography currently in production.

  1. JKPPORTRAIT RESERVED
    01

    John K. Park

    Chairman & Chief Executive Officer

    Corporate strategy · Strategic industries · Commercial execution

    John K. Park leads JP3E Holdings and serves as the company’s principal executive for its public-company and strategic-platform initiatives. JP3E’s public announcements identify him as the operating lead for strategic-materials execution and company development.

  2. HJPORTRAIT RESERVED
    02

    Henry Ji, Ph.D.

    Member, Board of Directors

    Public-company leadership · Life sciences · Strategic growth

    Dr. Ji is Executive Chairperson, President and Chief Executive Officer of Scilex Holding Company. His disclosed experience includes senior executive and board leadership across biotechnology and life-science companies.

  3. SMPORTRAIT RESERVED
    03

    Stephen Ma

    Member, Board of Directors

    Capital markets · Finance · Public-company operations

    Stephen Ma serves as Chief Financial Officer, Chief Operating Officer, Corporate Secretary and a Director of Scilex Holding Company. His background spans finance, accounting and operating leadership.

  4. JYPORTRAIT RESERVED
    04

    Jaedong Yoon

    Member, Board of Directors

    Institutional strategy · Governance · U.S.–Korea execution

    Jaedong Yoon serves as Chief Executive Officer of JP3E Development Corp. and as a Senior Advisor to Murua Korea Corp. His disclosed experience covers governance, institutional finance and international business coordination.

Roles and biographical information reflect JP3E public announcements as of August 14, 2026. View the Board appointment announcement ↗

Governance for Long-Term Execution.

Investor Information